Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma
About this episode
Shahad Abdulsahib discusses the phase 1/2 BT008NA clinical trial evaluating microbubble-enhanced transcranial focused ultrasound combined with temozolomide in patients with newly diagnosed high-grade glioma.
Host/Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio Description: Shahad Abdulsahib discusses the phase 1/2 BT008NA clinical trial evaluating microbubble-enhanced transcranial focused ultrasound combined with temozolomide in patients with newly diagnosed high-grade glioma, with findings published in The Lancet Oncology in December 2025
More episodes of Neuro-Oncology: The Podcast
- Author Interview: Prospective biopsy-controlled validation of an AI model for predicting glioblastoma infiltration: Results from the SupraGlio trial
- Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma
- Author Interview Series SNO Podcast May 2026
- Neuro-Oncology Narrative
- Hot Topics: Wellness in Neuro-oncology
- SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology
Explore listener stats, chart rankings, contacts and more on the Neuro-Oncology: The Podcast podcast page.